Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?

Nat Rev Rheumatol. 2009 Jul;5(7):361-3. doi: 10.1038/nrrheum.2009.120.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy*
  • Herpes Zoster / epidemiology
  • Herpes Zoster / etiology*
  • Humans
  • Immunocompromised Host
  • Risk Assessment
  • Risk Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • United States / epidemiology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha